Wilson Aaron S, Slager Stacey, Jones Aubrey E, Vazquez Sara R, Barnes Geoffrey D, Sylvester Katelyn, Chan Linh, Ragheb Bishoy, Witt Daniel M
Pharmacotherapy Department, University of Utah College of Pharmacy, Salt Lake City, Utah, USA.
Thrombosis Service, University of Utah Health, Salt Lake City, Utah, USA.
J Am Coll Clin Pharm. 2023 Dec;6(12):1295-1303. doi: 10.1002/jac5.1879. Epub 2023 Sep 10.
Despite consensus guideline recommendations, the use of warfarin patient self-management (PSM) in the US healthcare system remains small in comparison to European countries.
To gain understanding of the barriers and facilitators to warfarin PSM in US healthcare systems through exploration of the opinions of select US anticoagulation management service providers.
Focus group discussions were conducted at five geographically diverse sites. Grounded theory analysis was performed on focus group transcriptions using the consolidated framework for implementation research (CFIR) to identify facilitators and barriers to PSM implementation within the US healthcare system.
A total of 29 providers participated in eight focus group sessions. Five major themes emerged from the interviews: (1) "Ideal" PSM candidates possess identifiable characteristics (CFIR domain "Characteristics of Individuals"); (2) Providers harbor fears and lack familiarity with PSM facts and principles (CFIR domains "Characteristics of Individuals"; "Inner Setting"; and "Outer Setting"); (3) Providers mistrust patients' capability to engage in PSM (CFIR domains "Characteristics of Individuals"; "Inner Setting"; "Outer Setting"; and "Process"); (4) Despite acknowledging PSM advantages many providers cite workflow issues as barriers to implementation (CFIR domains "Intervention Characteristics"; "Inner Setting"; "Outer Setting"; and "Process"); and (5) Providers differed on how to best train patients to do PSM (CFIR domains "Intervention Characteristics"; and "Inner Setting").
Provider concern for patient safety contributes to hesitancy to relinquish control and mistrust of patients' ability to participate in PSM. Education and implementation strategies will be key to overcoming barriers to PSM in the United States.
尽管有共识性指南推荐,但与欧洲国家相比,美国医疗系统中使用华法林患者自我管理(PSM)的情况仍然较少。
通过探讨美国部分抗凝管理服务提供者的意见,了解美国医疗系统中华法林PSM的障碍和促进因素。
在五个地理位置不同的地点进行了焦点小组讨论。使用实施研究综合框架(CFIR)对焦点小组记录进行扎根理论分析,以确定美国医疗系统中PSM实施的促进因素和障碍。
共有29名提供者参加了八次焦点小组会议。访谈中出现了五个主要主题:(1)“理想”的PSM候选人具有可识别的特征(CFIR领域“个体特征”);(2)提供者心存担忧,且对PSM的事实和原则缺乏了解(CFIR领域“个体特征”、“内部环境”和“外部环境”);(3)提供者不信任患者参与PSM的能力(CFIR领域“个体特征”、“内部环境”、“外部环境”和“过程”);(4)尽管承认PSM的优势,但许多提供者将工作流程问题视为实施障碍(CFIR领域“干预特征”、“内部环境”、“外部环境”和“过程”);(5)提供者在如何最好地培训患者进行PSM方面存在分歧(CFIR领域“干预特征”和“内部环境”)。
提供者对患者安全问题的担忧导致他们不愿放弃控制权,且不信任患者参与PSM的能力。教育和实施策略将是克服美国PSM障碍的关键。